|
Volumn 4, Issue 11, 1999, Pages 497-506
|
Growth hormone secretagogues: Recent advances and applications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 (2 HYDROXYPROPYLAMINO) 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE;
3 (AMINOMETHYL)BENZOIC ACID N METHYL DEXTRO (2 NAPHTHYL)ALANYL N METHYL DEXTRO PHENYLALANINOL;
3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE;
CAPROMORELIN;
EP 51319;
EP 51389;
G 7039;
G 7502;
GROWTH HORMONE RELEASING FACTOR;
GROWTH HORMONE RELEASING FACTOR DERIVATIVE;
HEXARELIN;
HORMONE RECEPTOR;
HUMAN GROWTH HORMONE;
IBUTAMOREN;
IPAMORELIN;
L 163833;
NNC 26 0610;
NNC 26 0722;
RECEPTOR SUBTYPE;
TABIMORELIN;
UNCLASSIFIED DRUG;
AGED;
AMINO ACID COMPOSITION;
DOG;
DRUG BIOAVAILABILITY;
GROWTH HORMONE DEFICIENCY;
GROWTH HORMONE RELEASE;
HUMAN;
HYPOPHYSIS;
HYPOTHALAMUS;
IN VITRO STUDY;
METABOLIC DISORDER;
NONHUMAN;
OBESITY;
ORAL DRUG ADMINISTRATION;
REVIEW;
STRUCTURE ACTIVITY RELATION;
SWINE;
|
EID: 0033230733
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(99)01415-4 Document Type: Review |
Times cited : (12)
|
References (87)
|